Results 131 to 140 of about 12,496 (164)

[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Lin YY, Liu F, Rao HY.
europepmc   +1 more source

[Research advances in autoimmune liver disease in 2025: toward precision regulation and personalized treatment]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Shang YL, Han Y.
europepmc   +1 more source

[Role of Kupffer cells in liver regeneration with metabolic associated fatty liver disease in mice]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang TW, Liu L, Wang SY, Cheng LL, Wang X, Cao YN, Wang YF, Yang LM.   +7 more
europepmc   +1 more source

[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wu ST, Lu XL.
europepmc   +1 more source

[Research progress on autoimmune liver disease in 2024]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zheng LH, Han Y.
europepmc   +1 more source

[Exposures to volatile organic compounds are positively correlated with risks of metabolic dysfunction-associated steatotic liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li K, Zeng W, Zhang Y, Zhu X, Guo B.
europepmc   +1 more source

[Dosage optimization of major components of Yinchenhao decoction for metabolic associated fatty liver disease and its mechanism: an experimental study]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Gao Y, Xue R, Xu F, Chen L, Qiu J, Dou X.   +5 more
europepmc   +1 more source

功能糖的抗肿瘤和防治肝病作用

, 2009
杜昱光, 许青松
core  

[Risk Factors and Etiology of Pulmonary Fungal Infection in Patients With End-Stage Liver Disease]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Liu Q, Li J, Wang W, Zhao X.
europepmc   +1 more source